Datametrex AI Limited (the “
Company” or
“
Datametrex”) (TSXV:DM) (FSE:D4G) is pleased to
announce that its subsidiary company Graph Blockchain Limited has
signed a Collaboration Agreement with Revive Therapeutics Ltd.
("
Revive") (TSXV:RVV) (OTCQB:RVVTF) to develop the
blockchain component in Revive’s proprietary patient-focused
program enabled by artificial intelligence (“AI”) dedicated to the
medical cannabis industry.
This agreement is in addition to the previously announced
contract between Nexalogy and Revive on November 27, where Nexalogy
will use its proprietary social data discovery solution,
NexaIntelligence, to unlock the value of data related to medical
cannabis collected from social media networks and internet
environments such as discussion forums, blogs and news
sites.
“The collaboration with Graph Blockchain complements our current
relationship with Datametrex’s AI subsidiary, Nexalogy, and is an
important piece of our plan in building our concept of a
patient-focused platform enabled by AI for the medical cannabis
industry,” said Fabio Chianelli, President of Revive.
Andrew Ryu, Chairman and CEO of Datametrex AI stated, “We are
thrilled to sign a second contract with Revive and look forward to
developing a complete package of Blockchain and Artificial
Intelligence solutions for them. This is an explosive area and our
solutions will assist Revive in delivering vital data for patients.
We are in talks with a number of Marijuana Licensed Producers and
see an opportunity for Datametrex AI and Graph Blockchain solutions
to become the leader in providing these solutions for the Cannabis
sector.”
About Revive Therapeutics Ltd.
Revive Therapeutics Ltd. is focused on the research, development
and commercialization of novel therapies and technologies for the
medical cannabis and pharmaceutical sectors.
Additional information on Revive is available at:
www.ReviveThera.com.
About the Company
Datametrex AI Limited is focused on the
collection of retail sales data, providing Government Agencies and
Fortune 500 corporations with Artificial Intelligence solutions and
implementing Blockchain technology for secure Data Transfers and
Cryptocurrency Mining.
Additional information on Datametrex is
available at: www.datametrex.com.
To stay informed about Datametrex,
please join our Investor Group on 8020
Connect http://bit.ly/2fPUNwF for
all upcoming news releases, articles comments and
questions.
For further information, please
contact:
Jeffrey Stevens – President & COOPhone:
(647) 400-8494Email: jstevens@datametrex.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Forward-Looking Statements
This news release includes certain
forward-looking statements within the meaning of Canadian
securities laws. Such forward-looking information and statements
are not representative of historical facts or information or
current condition, but instead represent only the Company`s belief
regarding future events, plans or objectives, many of which, by
their nature, are inherently uncertain and outside of the Company’s
control.
Generally, such forward-looking information or
statements can be identified by the use of forward-looking
terminology such as “plans”, “expects” or “does not expect”, “is
expected”, “budget”, “scheduled”, “estimates”, “forecasts”,
“intends”, “anticipates” or “does not anticipate”, or “believes”,
or variations of such words and phrases or may contain statements
that certain actions, events or results “may”, “could”, “would”,
“might” or “will be taken”, “will continue”, “will occur” or “will
be achieved”.
The forward-looking information contained herein
includes, but is not limited to, information with respect to
prospective financial performance, anticipated capital funding and
sources, proposed or potential acquisitions, estimated operating
and sales costs, estimated market drivers and demand, business
prospects and strategy, new markets for growth and financial
position. By identifying such information and statements in this
manner, the Company is alerting the reader that such information
and statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
information and statements.
Although the Company believes that the
assumptions and factors used in preparing, and the expectations
contained in, the forward-looking information and statements are
reasonable, undue reliance should not be placed on such information
and statements, and no assurance or guarantee can be given that
such forward-looking information and statements will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such information and
statements. Accordingly, readers should not place undue reliance on
any forward-looking information or statements contained in this
press release.
The forward-looking information contained in
this press release is made as of the date hereof, and the Company
does not undertake to update any forward-looking information that
is contained or referenced herein, whether as a result of new
information, future events or otherwise, except in accordance with
applicable securities laws. All subsequent written and oral forward
looking information and statements attributable to the Company or
persons acting on its behalf are expressly qualified in its
entirety by this notice.
Revive Therapeutics (TSXV:RVV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Revive Therapeutics (TSXV:RVV)
Historical Stock Chart
From Apr 2023 to Apr 2024